Anti-neutrophil cytoplasmic autoantibodies against bactericidal/ permeability-increasing protein in patients with rheumatoid arthritis and their correlation with bronchial involvement

Modern Rheumatology

Volumn 20, Issue 3, 2010, Pages 252-256

  Wada, Yoko ^a   Kuroda, Takeshi ^a   Murasawa, Akira ^b   Nakano, Masaaki ^c   Narita, Ichiei ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Niigata Rheumatic Center   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

BPI ANCA; Bronchial disease; RA lung; Rheumatoid arthritis

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PLASMA PROTEIN;

AGED; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; JOINT; LUNG DISEASE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RHEUMATOID ARTHRITIS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIMICROBIAL CATIONIC PEPTIDES; ARTHRITIS, RHEUMATOID; BLOOD PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; JOINTS; LUNG DISEASES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 77956645360     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0270-1     Document Type: Article

References (16)

1. Weiss J, Elsbach P, Olsson I, Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem. 1978;253:2664-72. (Pubitemid 8328425)
2. Zhao MH, Jones SJ, Lockwood CM. Bactericidal/permeability increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol. 1995;99:49-56.
3. Schultz H. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). Autoimmun Rev. 2007;6:223-7. (Pubitemid 46274546)
4. Schultz H, Weiss J, Carroll SF, Gross WL. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies. J Leukoc Biol. 2001;69:505-12. (Pubitemid 32294834)
5. Mahadeva R, Dunn AC, Westerbeek RC, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin Exp Immunol. 1999;117:561-7. (Pubitemid 29398306)
6. Shinke S, Fellermann K, Herlyn K, et al. Autoantibodies against the bactericidal/permeability-increasing protein (BPI) from inflammatory bowel disease patients can impair the antibiotic activity of BPI. Inflamm Bowel Dis. 2004;10:763-70. (Pubitemid 39545222)
7. Manolova I, Dancheva M, Halacheva K. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol Int. 2001;20:197-204. (Pubitemid 32662567)
8. Khanna D, Aggarwal A, Bhakuni DS, Dayal R, Misra R. Bactericidal/ permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol. 2003;30:1248-52. (Pubitemid 36666349)
9. Manolova I, Dantcheva M. Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations. Rheumatol Int. 2005;26:107-14. (Pubitemid 41779818)
10. Ohtami S, Kobayashi O, Ohtami H. Analysis of intractable factors in chronic airway infections: role of the autoimmunity induced by BPI-ANCA. J Infect Chemother. 2001;7:228-38. (Pubitemid 34101072)
11. Bilgici A, Ulusoy H, Kuru O, Celenk C, Unsal M, Danaci M. Pulmonary involvement in rheumatoid arthritis. Rheumatol Int. 2005;25:429-35. (Pubitemid 41186911)
12. Vergnenegre A, Pugnere N, Antonini MT, et al. Airway obstruction and rheumatoid arthritis. Eur Resp J. 1997;10:1072-8. (Pubitemid 27201812)
13. Swinson DR, Symons D, Suresh U, Jones M, Booth M. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol. 1997;36:689-91.
14. Kobayashi H. Airway biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. J Infect Chemother. 1995;1:1-15.
15. Blander JM, Medzhiov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature. 2006;440:808-12.
16. Mustila A, Paimela L, Leirisalo-Repo M, Huhtala H, Miettinen A. Antineutrophil cytoplasmic antibodies in patient with early rheumatoid arthritis. Arthritis Rheum. 2000;43:1371-7.